Decheng Ma, PhD

CEO
Crystal Formulation Services

Decheng Ma is the co-founder and CEO of Crystal Formulation Services (CFS), the CDMO Business Unit of Crystal Pharmatech. He has over 26 years of formulation development and CRO/CDMO/CMO CRDMO vendor management experience mostly at Merck (US) and MSD (China). MSD (US and China). His expertise is oral solid formulation development, analytical science, and clinical supply. He has led or supported supported over 30 new drug formulation development with 5 of which were commercialized.

Poster(s):

• (T1330-08-52) Developing a Minitablet Formulation for an NCE to Enable Dose and Administration Flexibility in Pediatric Clinical Trials
  Tuesday, November 11, 2025

  1:30 PM - 2:30 PM CT

• (T1430-08-52) Overcoming Formulation Challenges of an Unstable Amorphous Prodrug by API Sparing and Enteric Coating Approaches
  Tuesday, November 11, 2025

  2:30 PM - 3:30 PM CT

• (T1530-08-52) Development of a Gastro-Retentive Bimodal Release Bilayer Tablet to Enable Once-Daily Dosing, Fast Onset and Blunted C_max for an NCE with Short Half-Life
  Tuesday, November 11, 2025

  3:30 PM - 4:30 PM CT